Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the

Ohad Atia1, Rachel Buchuk1, Rona Lujan1

  • 1Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel.

PubMed

Insights

Predictors of complicated ulcerative colitis (UC) include younger age, extraintestinal manifestations, and specific induction therapies. Pediatric-onset UC has a higher risk of complicated disease course within five years.

Area of Science:

  • Gastroenterology
  • Clinical Epidemiology
  • Inflammatory Bowel Disease Research

Background:

  • Limited data exists on predictors for complicated ulcerative colitis (UC) courses in unselected populations.
  • Understanding these predictors is crucial for early intervention and improved patient outcomes.
  • Nationwide cohorts offer a valuable resource for identifying such predictors.

Purpose of the Study:

  • To identify predictors at diagnosis for complicated disease course in pediatric and adult UC patients.
  • To analyze the association between baseline laboratory markers and disease severity.
  • To compare disease course probabilities between pediatric-onset and adult-onset UC.

Main Methods:

  • Utilized the nationwide epi-IIRN cohort data for patients diagnosed with UC since 2005.
  • Defined complicated disease course as colectomy, steroid-dependency, or need for biologic drugs.
  • Employed hierarchical clustering on complete blood count, albumin, C-reactive protein, and ESR to categorize disease severity at diagnosis.

Main Results:

  • Included 13,471 UC patients (1427 pediatric-onset) with 103,212 person-years follow-up.
  • Complicated disease course occurred in 21% of patients; 5-year probabilities were 32% for pediatric-onset vs. 16% for adult-onset UC.
  • Cox model identified steroid induction therapy, extraintestinal manifestations, and severe lab clusters as predictors of complicated course; enema induction and older age were protective.

Conclusions:

  • The 5-year probability of a complicated UC course is significantly higher in pediatric-onset disease.
  • Routinely collected laboratory tests, younger age at diagnosis, extraintestinal manifestations, and induction therapy type are key predictors.
  • These findings highlight the importance of early risk stratification in UC management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
165
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
442
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
217
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
144